Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9918563 | International Journal of Pharmaceutics | 2005 | 6 Pages |
Abstract
Spray-freeze drying was utilized to manufacture a liposomal powder formulation containing ciprofloxacin as a model active component. The powder forms liposomally encapsulated ciprofloxacin when wetted. Aerosol properties of this formulation were assessed using a new passive inhaler, in which the powder was entrained at a flow rate of 60 l/min. A mass median aerodynamic diameter (MMAD) of 2.8 μm was achieved for this formulation. Using the experimental dispersion testing data, ciprofloxacin concentration in the airway surface liquid (ASL) was calculated using a Lagrangian deposition model. The reconstitution of the powder in various aqueous media gave drug encapsulation efficiencies as follows: 50% in water, 93.5% in isotonic saline, 80% in bovine mucin, 75% in porcine mucus and 73% in five-fold-diluted ex vivo human cystic fibrosis patient sputum.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
Lyle G. Sweeney, Zhaolin Wang, Raimar Loebenberg, Jonathan P. Wong, Carlos F. Lange, Warren H. Finlay,